Thursday, December 4, 2008

Wockhardt receives US FDA nod for generic version of Augmentin

Wockhardt's Chicago-based subsidiary Morton Grove Pharmaceuticals has received US FDA approval for marketing an oral suspension of a combination containing 250mg/5ml of amoxicillin and 62.5mg/5ml of clavulanate potassium. This combination is used for treating several common infections, especially in children.

The details can be read here.

No comments: